Citation: S. Honma et al., HUMAN ASTROCYTOMA-CELLS EXPRESS 2 THROMBOXANE A(2) RECEPTOR SUBTYPES THAT COMMUNICATE WITH G(Q) AND G(12), PROSTAGLANDINS & OTHER LIPID MEDIATORS, 55(2-3), 1998, pp. 159-168
Authors:
KUTSUWA M
NAKAHATA N
KUBO M
HAYASHI K
OHIZUMI Y
Citation: M. Kutsuwa et al., A COMPARATIVE-STUDY OF KAKKON-TO AND KEISHI-TO ON PROSTAGLANDIN E-2 RELEASE FROM RABBIT ASTROCYTES, Phytomedicine, 5(4), 1998, pp. 275-282
Authors:
KYO R
NAKAHATA N
SAKAKIBARA I
KUBO M
OHIZUMI Y
Citation: R. Kyo et al., EFFECTS OF SHO-SAIKO-TO, SANO-SHASHIN-TO AND SCUTELLARIAE-RADIX ON INTRACELLULAR CA2-CELLS( MOBILIZATION IN C6 RAT GLIOMA), Biological & pharmaceutical bulletin, 21(10), 1998, pp. 1067-1071
Authors:
TADANO T
TAKAHASHI N
NAKAGAWASAI O
TANNO K
KANEKO S
MATSUNAGA K
OHIZUMI Y
KISARA K
Citation: T. Tadano et al., CENTRAL ACTION OF 9-METHYL-7-BROMOEUDISTOMIN-D (MBED), A DERIVATIVE OF EUDISTOMIN-D ISOLATED FROM EUDISTOMA-OLIVACEUM, Methods and findings in experimental and clinical pharmacology, 20(1), 1998, pp. 53-58
Authors:
OHTA T
KITA T
KOBAYASHI N
OBARA Y
NAKAHATA N
OHIZUMI Y
TAKAYA Y
OSHIMA Y
Citation: T. Ohta et al., SCABRONINE-A, A NOVEL DITERPENOID HAVING POTENT INDUCTIVE ACTIVITY OFTHE NERVE GROWTH-FACTOR SYNTHESIS, ISOLATED FROM THE MUSHROOM, SARCODON-SCABROSUS, Tetrahedron letters, 39(34), 1998, pp. 6229-6232
Authors:
FURUKAWA K
OHKURA M
FUJIMORI H
KURUMA A
NOMURA A
KAWANO S
HIRAOKA M
KUNIYASU A
NAKAYAMA H
OHIZUMI Y
Citation: K. Furukawa et al., REGULATION OF THE SKELETAL-MUSCLE RYANODINE RECEPTOR BY TRIADIN AND CALSEQUESTRIN, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 262-262
Citation: N. Nakahata et al., EFFECT OF ZOOXANTHELLATOXIN-A, AN UNIQUE MARINE MACROLIDE, ON ARACHIDONIC-ACID CASCADE IN RABBIT PLATELETS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 422-422
Authors:
OHIZUMI Y
CHAIRUNGSRILERD N
YOSHIDA A
FURUKAWA K
MATSUNAGA K
Citation: Y. Ohizumi et al., PHAMACOLOGICAL PROPERTIES OF NOVEL SEROTONIN ANTAGONISTS FROM NATURAL-RESOURCES, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 817-817
Authors:
CHAIRUNGSRILERD N
FURUKAWA K
OHTA T
NOZOE S
OHIZUMI Y
Citation: N. Chairungsrilerd et al., GAMMA-MANGOSTIN, A NOVEL TYPE OF 5-HYDROXYTRYPTAMINE 2A RECEPTOR ANTAGONIST, Naunyn-Schmiedeberg's archives of pharmacology, 357(1), 1998, pp. 25-31
Authors:
OHIZUMI Y
MATSUNAGA K
NAKATANI K
KOBAYASHI J
Citation: Y. Ohizumi et al., POTENT STIMULATION OF MYOFILAMENT FORCE AND ATPASE ACTIVITY OF SKELETAL-MUSCLE BY EUDISTOMIN-M, A NOVEL CA-SENSITIZING AGENT FROM A CARIBBEAN TUNICATE(+), The Journal of pharmacology and experimental therapeutics, 285(2), 1998, pp. 695-699
Authors:
OHIZUMI Y
MATSUNAGA K
NAKATANI K
KOBAYASHI J
Citation: Y. Ohizumi et al., THE POWERFUL STIMULATORY ACTION OF 6-O-ACETYL-9-METHYL-7-BROMOEUDISTOMIN-D ON THE CONTRACTILE PROTEIN SYSTEM OF RABBIT SKELETAL-MUSCLE, Japanese Journal of Pharmacology, 76(1), 1998, pp. 113-116
Citation: Mc. Rho et al., 2 DISTINCT EFFECTS OF 12S-HYDROXYEICOSATETRAENOIC ACID ON PLATELET-AGGREGATION BY ZOOXANTHELLATOXIN-A AND IONOMYCIN, Japanese Journal of Pharmacology, 76(1), 1998, pp. 117-120
Authors:
SEINOUMEDA A
FANG YI
ISHIBASHI M
KOBAYASHI J
OHIZUMI Y
Citation: A. Seinoumeda et al., 9-METHYL-7-BROMOEUDISTOMIN-D INDUCES CA2-RETICULUM( RELEASE FROM CARDIAC SARCOPLASMIC), European journal of pharmacology, 357(2-3), 1998, pp. 261-265
Authors:
NAKATANI K
NAKAHATA N
HAMADA Y
TSURUFUJI S
OHIZUMI Y
Citation: K. Nakatani et al., MEDIUM CHANGE AMPLIFIES MITOGEN-ACTIVATED PROTEIN KINASE-MEDIATED PROSTAGLANDIN E-2 SYNTHESIS IN SWISS 3T3 FIBROBLASTS, European journal of pharmacology, 356(1), 1998, pp. 91-100
Authors:
MORIYA T
ISHIDA Y
NAKAMURA H
ASARI T
MURAI A
OHIZUMI Y
Citation: T. Moriya et al., VASOCONSTRICTION INDUCED BY ZOOXANTHELLATOXIN-B, A POLYOXYGENATED LONG-CHAIN PRODUCT FROM A MARINE ALGA, European journal of pharmacology, 350(1), 1998, pp. 59-65
Authors:
YASUDA M
NAKATANI K
MATSUNAGA K
MURAKAMI M
MOMOSE K
OHIZUMI Y
Citation: M. Yasuda et al., MODULATION OF ACTOMYOSIN ATPASE BY GONIODOMIN A DIFFERS IN TYPES OF CARDIAC MYOSIN, European journal of pharmacology, 346(1), 1998, pp. 119-123
Authors:
KATAGIRI C
ISHIKAWA HH
OHKURA M
NAKAGAWASAI O
TADANO T
KISARA K
OHIZUMI Y
Citation: C. Katagiri et al., PROPERTIES OF SPECIFIC BINDING-SITE OF MYOTOXIN A, A POWERFUL CONVULSANT, IN BRAIN MICROSOMES, Canadian journal of physiology and pharmacology, 76(4), 1998, pp. 395-400
Authors:
CHAIRUNGSRILERD N
FURUKAWA K
TADANO T
KISARA K
OHIZUMI Y
Citation: N. Chairungsrilerd et al., EFFECT OF GAMMA-MANGOSTIN THROUGH THE INHIBITION OF 5-HYDROXY-TRYPTAMINE(2A) RECEPTORS IN 5-FLUORO-ALPHA-METHYLTRYPTAMINE-INDUCED HEAD-TWITCH RESPONSES OF MICE, British Journal of Pharmacology, 123(5), 1998, pp. 855-862
Citation: Y. Obara et al., A NEW FACTOR DERIVED FROM 1321N1 HUMAN ASTROCYTOMA-CELLS CAUSES DIFFERENTIATION OF PC-12 CELLS MEDIATED THROUGH MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE, Brain research, 806(1), 1998, pp. 79-88
Authors:
OHKURA M
FURUKAWA KI
FUJIMORI H
KURUMA A
KAWANO S
HIRAOKA M
KUNIYASU A
NAKAYAMA H
OHIZUMI Y
Citation: M. Ohkura et al., DUAL REGULATION OF THE SKELETAL-MUSCLE RYANODINE RECEPTOR BY TRIADIN AND CALSEQUESTRIN, Biochemistry (Easton), 37(37), 1998, pp. 12987-12993
Authors:
TSURUOKA T
OHIZUMI Y
USHIODA S
OHNO Y
OHNO H
Citation: T. Tsuruoka et al., LIGHT-EMISSION SPECTRA OF ALGAAS GAAS MULTIQUANTUM WELLS INDUCED BY SCANNING TUNNELING MICROSCOPE/, Applied physics letters, 73(11), 1998, pp. 1544-1546
Authors:
FURUKAWA KI
OHKURA M
KUNIYASU A
NAKAYAMA H
OHIZUMI Y
Citation: Ki. Furukawa et al., REGULATION OF THE SKELETAL-MUSCLE RYANODINE RECEPTOR BY TRIADIN AND CALSEQUESTRIN, The FASEB journal, 11(9), 1997, pp. 654-654
Citation: Mc. Rho et al., A MONOGALACTOPYRANOSYL ACYLGLYCEROL FROM OLTMANNSIELLOPSIS-UNICELLULARIS (NIES-359), Phytochemistry, 44(8), 1997, pp. 1507-1509
Authors:
RHO MC
NAKAHATA N
NAKAMURA H
MURAI A
OHIZUMI Y
Citation: Mc. Rho et al., INVOLVEMENT OF PHOSPHOLIPASE C-GAMMA-2 IN ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE AND PHOSPHOLIPASE A(2) BY ZOOXANTHELLATOXIN-A IN RABBIT PLATELETS, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 496-504